LONRF2

Model summary

A nuclear scaffold that organizes ubiquitination and proteasome-directed protein turnover. Its N-terminal helical solenoid and internal repeats create a multivalent platform that captures client proteins and assembly factors, while two RING modules catalyze and regulate ubiquitin transfer and autoubiquitination. A C-terminal Lon protease–related and PUA-like platform stabilizes higher-order assemblies and substrate engagement. Together these modules concentrate ubiquitination machinery in the nucleus, promote substrate ubiquitination, and enhance proteasome-dependent degradation pathways.

Predicted Gene Ontology terms

1. 01

   I begin by dissecting the domain architecture.

   The N-terminus carries IPR011990 (Tetratricopeptide-like helical domain superfamily, residues 19–102), followed by a second helical scaffold IPR011990 segment (residues 195–311). Within this N-terminal-to-mid region, there is a defined TPR array: IPR019734 repeat units occur consecutively at residues 197–230, 231–264, and 265–298. TPR-like solenoids create extended protein–protein interaction surfaces that recruit client proteins and assembly factors; this architecture causes multivalent protein binding and scaffolding, supporting GO:0005515 protein binding as a core molecular function.

2. 02

   Immediately downstream, two RING-type zinc-finger modules are present.

   The first is a canonical RING region: IPR001841 (Zinc finger, RING-type, residues 143–193) embedded within IPR013083 (Zinc finger, RING/FYVE/PHD-type superfamily, residues 134–194). A second RING module appears later: IPR001841 (Zinc finger, RING-type, residues 448–487) within IPR013083 (residues 415–518), with a conserved site IPR017907 (Zinc finger, RING-type, conserved site, residues 464–473). RING domains catalyze ubiquitin transfer by coordinating E2~Ub thioesters and positioning substrates; thus, this dual RING layout equips the protein both to assemble ubiquitination machinery and to undergo GO:0051865 protein autoubiquitination. The presence of two RING modules suggests either sequential E2 engagements or auto-regulatory ubiquitin tagging that tunes activity and localization.

3. 03

   The C-terminal half transitions into an Lon protease–related scaffold: IPR046336 (Lon protease, N-terminal domain superfamily, residues 519–636) and IPR003111 (Lon protease, N-terminal domain, residues 528–737), accompanied by IPR015947 (PUA-like superfamily, residues 537–733).

   Lon N-terminal and PUA-like folds form β-barrel/α-solenoid assemblies that bind RNA and acidic/basic patches on client proteins; in this context they function as an oligomerization and substrate-handling platform rather than a catalytic protease. Together with the N-terminal TPR array, this creates a bipartite solenoidal chassis that captures, organizes, and hands off substrates to ubiquitin machinery.

4. 04

   From these features, the molecular function resolves as multivalent protein binding (GO:0005515) with embedded ubiquitin-transfer capacity via RING fingers.

   The biological process follows causally: the TPR and Lon-like scaffolds concentrate substrates and E3/E2 components, while the RING modules drive ubiquitin attachment, establishing GO:0016567 protein ubiquitination. The same architecture explains GO:0032436 positive regulation of proteasomal ubiquitin-dependent protein catabolic process: by scaffolding E2/E3 modules and funneling ubiquitinated clients toward the proteasome, the protein enhances proteasomal flux. Autoubiquitination (GO:0051865) emerges naturally from the dual RING arrangement and provides a feedback mechanism for turnover and trafficking.

5. 05

   Cellular location is inferred from function and architecture.

   The absence of transmembrane segments and the presence of nuclear-associated scaffolding argue for a soluble nuclear role. The stated nuclear enrichment aligns with assembly of ubiquitination hubs that regulate chromatin-associated and transcriptional substrates; thus the cellular component is the GO:0005634 nucleus.

6. 06

   Mechanistically, the protein operates as a nuclear E3-scaffold.

   The N-terminal TPR solenoid recruits client proteins and adaptors; the first RING domain nucleates ubiquitin transfer; the C-terminal Lon/PUA-like platform stabilizes higher-order assemblies and substrate engagement; the second RING module modulates activity and supports autoubiquitination. This architecture causes efficient substrate capture and handoff to E2/E3 partners, thereby promoting proteasome-directed degradation. Likely interaction partners include nuclear E2 conjugating enzymes and E3s that cooperate with RING scaffolds, as well as proteasome receptors and RNA-associated factors that localize substrates in the nucleus. I therefore hypothesize transient complexes with ubiquitin-conjugating enzymes and nuclear proteostasis hubs that together tune ubiquitin signaling and proteasomal throughput.